๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Response to Imatinib mesylate in chronic myeloid leukemia patients with variant BCR-ABL fusion transcripts

โœ Scribed by Pratibha Sharma; Lalit Kumar; Sujata Mohanty; Vinod Kochupillai

Book ID
105989466
Publisher
Springer
Year
2009
Tongue
English
Weight
122 KB
Volume
89
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Molecular response to imatinib in patien
Molecular response to imatinib in patient with Ph negative p190 BCRโ€“ABL transcript positive chronic myeloid leukemia with cyclic leukocytosis
โœ M. Radojkovic; S. Ristic; S. Pavlovic; M. Colovic ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 181 KB

An atypical case of Philadelphia (Ph) negative, e1a2 BCR-ABL transcript positive chronic myeloid leukemia (CML) characterized with cyclic periodic leukocytosis and spontaneous remissions is reported. The patient was treated with imatinib and good hematology response with molecular remission was achi

Isolated thrombocytosis as first sign of
Isolated thrombocytosis as first sign of chronic myeloid leukemia with e6a2 BCR/ABL fusion transcript, JAK2 negativity and complete response to imatinib
โœ Massimo Breccia; Laura Cannella; Daniela Diverio; Paola Streponi; Mauro Nanni; C ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 91 KB

Since very few unusual BCR/ABL fusion transcripts in chronic myeloid leukemia have been reported, no clear evidence exists concerning their clinical and prognostic implications. We describe here a CML case with normal karyotype at standard cytogenetics and an atypical e6a2 BCR/ABL fusion transcript,